Log in
Enquire now
‌

US Patent 8299057 Substituted indazole derivatives active as kinase inhibitors

Patent 8299057 was granted and assigned to Nerviano Medical Sciences on October, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Nerviano Medical Sciences
Nerviano Medical Sciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
82990570
Patent Inventor Names
Ermes Vanotti0
Ettore Perrone0
Marcella Nesi0
Maria Menichincheri0
Paolo Orsini0
Achille Panzeri0
Andrea Lombardi Borgia0
Chiara Marchionni0
Date of Patent
October 30, 2012
0
Patent Application Number
126687450
Date Filed
July 8, 2008
0
Patent Citations Received
‌
US Patent 12090153 Combination therapy for the treatment of uveal melanoma
0
‌
US Patent 11851434 Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors
0
‌
US Patent 11964988 Fused heterocyclic compounds as RET kinase inhibitors
0
‌
US Patent 11969472 Tropomyosin receptor kinase (TRK) degradation compounds and methods of use
0
‌
US Patent 11998545 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
0
‌
US Patent 12065442 Tropomyosin receptor kinase (TRK) degradation compounds and methods of use
0
Patent Primary Examiner
‌
James O. Wilson
0
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8299057 Substituted indazole derivatives active as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.